vs

Side-by-side financial comparison of National Vision Holdings, Inc. (EYE) and STAAR SURGICAL CO (STAA). Click either name above to swap in a different company.

National Vision Holdings, Inc. is the larger business by last-quarter revenue ($487.3M vs $49.0M, roughly 10.0× STAAR SURGICAL CO). National Vision Holdings, Inc. runs the higher net margin — 0.7% vs -69.9%, a 70.6% gap on every dollar of revenue. On growth, National Vision Holdings, Inc. posted the faster year-over-year revenue change (7.9% vs -35.8%). National Vision Holdings, Inc. produced more free cash flow last quarter ($30.3M vs $-5.1M). Over the past eight quarters, National Vision Holdings, Inc.'s revenue compounded faster (7.6% CAGR vs -18.4%).

Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.

STAAR Surgical Co is a global ophthalmic medical device firm. It designs, makes and sells implantable collamer lenses (ICLs) for minimally invasive vision correction, plus supporting surgical products for ophthalmologists across North America, Europe, Asia Pacific and other key regional markets.

EYE vs STAA — Head-to-Head

Bigger by revenue
EYE
EYE
10.0× larger
EYE
$487.3M
$49.0M
STAA
Growing faster (revenue YoY)
EYE
EYE
+43.8% gap
EYE
7.9%
-35.8%
STAA
Higher net margin
EYE
EYE
70.6% more per $
EYE
0.7%
-69.9%
STAA
More free cash flow
EYE
EYE
$35.4M more FCF
EYE
$30.3M
$-5.1M
STAA
Faster 2-yr revenue CAGR
EYE
EYE
Annualised
EYE
7.6%
-18.4%
STAA

Income Statement — Q3 2026 vs Q4 2025

Metric
EYE
EYE
STAA
STAA
Revenue
$487.3M
$49.0M
Net Profit
$3.4M
$-34.2M
Gross Margin
64.7%
Operating Margin
2.0%
-57.0%
Net Margin
0.7%
-69.9%
Revenue YoY
7.9%
-35.8%
Net Profit YoY
139.8%
-541.3%
EPS (diluted)
$0.04
$-0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EYE
EYE
STAA
STAA
Q3 25
$487.3M
Q2 25
$486.4M
Q1 25
$510.3M
Q4 24
$437.3M
$49.0M
Q3 24
$451.5M
$88.6M
Q2 24
$451.7M
$99.0M
Q1 24
$482.8M
$77.4M
Q4 23
$421.0M
$76.3M
Net Profit
EYE
EYE
STAA
STAA
Q3 25
$3.4M
Q2 25
$8.7M
Q1 25
$14.2M
Q4 24
$-28.6M
$-34.2M
Q3 24
$-8.5M
$10.0M
Q2 24
$-3.1M
$7.4M
Q1 24
$11.7M
$-3.3M
Q4 23
$-16.0M
$7.8M
Gross Margin
EYE
EYE
STAA
STAA
Q3 25
Q2 25
Q1 25
Q4 24
64.7%
Q3 24
77.3%
Q2 24
79.2%
Q1 24
78.9%
Q4 23
79.6%
Operating Margin
EYE
EYE
STAA
STAA
Q3 25
2.0%
Q2 25
3.4%
Q1 25
5.1%
Q4 24
-5.8%
-57.0%
Q3 24
-2.0%
6.4%
Q2 24
0.1%
12.0%
Q1 24
4.9%
-2.9%
Q4 23
-2.9%
13.6%
Net Margin
EYE
EYE
STAA
STAA
Q3 25
0.7%
Q2 25
1.8%
Q1 25
2.8%
Q4 24
-6.5%
-69.9%
Q3 24
-1.9%
11.3%
Q2 24
-0.7%
7.5%
Q1 24
2.4%
-4.3%
Q4 23
-3.8%
10.2%
EPS (diluted)
EYE
EYE
STAA
STAA
Q3 25
$0.04
Q2 25
$0.11
Q1 25
$0.18
Q4 24
$-0.36
$-0.69
Q3 24
$-0.11
$0.20
Q2 24
$-0.04
$0.15
Q1 24
$0.15
$-0.07
Q4 23
$-0.17
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EYE
EYE
STAA
STAA
Cash + ST InvestmentsLiquidity on hand
$56.0M
$230.5M
Total DebtLower is stronger
$236.5M
Stockholders' EquityBook value
$858.8M
$397.3M
Total Assets
$2.0B
$509.5M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EYE
EYE
STAA
STAA
Q3 25
$56.0M
Q2 25
$48.5M
Q1 25
$80.0M
Q4 24
$73.9M
$230.5M
Q3 24
$81.2M
$236.0M
Q2 24
$179.5M
$235.2M
Q1 24
$150.1M
$245.1M
Q4 23
$149.9M
$220.7M
Total Debt
EYE
EYE
STAA
STAA
Q3 25
$236.5M
Q2 25
$255.6M
Q1 25
$244.7M
Q4 24
$248.6M
Q3 24
$252.8M
Q2 24
$143.9M
Q1 24
$448.6M
Q4 23
$450.8M
Stockholders' Equity
EYE
EYE
STAA
STAA
Q3 25
$858.8M
Q2 25
$850.6M
Q1 25
$836.2M
Q4 24
$816.3M
$397.3M
Q3 24
$840.0M
$428.1M
Q2 24
$843.4M
$409.1M
Q1 24
$841.3M
$392.8M
Q4 23
$829.4M
$386.0M
Total Assets
EYE
EYE
STAA
STAA
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
$509.5M
Q3 24
$2.0B
$537.6M
Q2 24
$2.1B
$512.7M
Q1 24
$2.2B
$492.5M
Q4 23
$2.2B
$488.7M
Debt / Equity
EYE
EYE
STAA
STAA
Q3 25
0.28×
Q2 25
0.30×
Q1 25
0.29×
Q4 24
0.30×
Q3 24
0.30×
Q2 24
0.17×
Q1 24
0.53×
Q4 23
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EYE
EYE
STAA
STAA
Operating Cash FlowLast quarter
$46.6M
$642.0K
Free Cash FlowOCF − Capex
$30.3M
$-5.1M
FCF MarginFCF / Revenue
6.2%
-10.4%
Capex IntensityCapex / Revenue
3.4%
11.7%
Cash ConversionOCF / Net Profit
13.83×
TTM Free Cash FlowTrailing 4 quarters
$83.0M
$-7.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EYE
EYE
STAA
STAA
Q3 25
$46.6M
Q2 25
$54.3M
Q1 25
$32.2M
Q4 24
$30.3M
$642.0K
Q3 24
$27.9M
$3.8M
Q2 24
$51.5M
$-10.4M
Q1 24
$24.0M
$21.7M
Q4 23
$19.8M
$32.0M
Free Cash Flow
EYE
EYE
STAA
STAA
Q3 25
$30.3M
Q2 25
$42.4M
Q1 25
$12.0M
Q4 24
$-1.7M
$-5.1M
Q3 24
$4.1M
$-2.4M
Q2 24
$31.9M
$-16.6M
Q1 24
$4.0M
$16.5M
Q4 23
$-13.0M
$28.9M
FCF Margin
EYE
EYE
STAA
STAA
Q3 25
6.2%
Q2 25
8.7%
Q1 25
2.4%
Q4 24
-0.4%
-10.4%
Q3 24
0.9%
-2.7%
Q2 24
7.1%
-16.8%
Q1 24
0.8%
21.3%
Q4 23
-3.1%
37.9%
Capex Intensity
EYE
EYE
STAA
STAA
Q3 25
3.4%
Q2 25
2.4%
Q1 25
4.0%
Q4 24
7.3%
11.7%
Q3 24
5.3%
7.0%
Q2 24
4.3%
6.3%
Q1 24
4.1%
6.7%
Q4 23
7.8%
4.0%
Cash Conversion
EYE
EYE
STAA
STAA
Q3 25
13.83×
Q2 25
6.22×
Q1 25
2.27×
Q4 24
Q3 24
0.38×
Q2 24
-1.41×
Q1 24
2.05×
Q4 23
4.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons